🆕
thesicktimes.org
30/06/2026
Will the new COVID-19 antiviral be accessible? - The Sick Times
In June, the Food and Drug Administration approved the drug Xocova (ensitrelvir) as the very first post-exposure prophylaxis for Sars-CoV-2, and if taken within 72 hours, it could stop a SARS-CoV-2 infection in its tracks. The drug is also being stud